Paediatric Allergy Policy Series

The Paediatric Allergy Policy Series explores how the National Health System (NHS) can deliver earlier identification and consistent, family-centred management of paediatric allergies across the NHS.

This series will bring together senior clinicians, commissioners, dietitians, pharmacists, and patient advocates to identify practical improvements that standardise pathways, reduce unwarranted variation, and improve outcomes for infants and families.

Programme Components

Invitation-only, closed-door roundtables with keynote speakers and open discussion
Policy reports summarising recommendations and outputs

Roundtable 1: What can we do today in CMPA to reduce future allergic manifestations?

Date: 13th March 2026 | Time: 13:00-14:30 UK Time (GMT)

Theme: Cow's Milk Protein Allergy Prevention and Health System Impact

Overview:

This roundtable will examine how prevention and early action can reduce time to diagnosis, avoid unnecessary prescribing, and improve growth and well-being outcomes for children presenting with CMPA. The discussion will focus on the health system impact of consistent, evidence-based pathways, including how integrated neighbourhood teams can support earlier recognition of both IgE and non-IgE presentations, effective safety-netting, and timely access to dietetic care.